Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Julphar
Federal Trade Commission
Fish and Richardson
AstraZeneca
Merck
Citi
Cantor Fitzgerald
Accenture

Generated: April 21, 2018

DrugPatentWatch Database Preview

Parkedale Company Profile

« Back to Dashboard

What is the competitive landscape for PARKEDALE, and what generic and branded alternatives to PARKEDALE drugs are available?

PARKEDALE has sixteen approved drugs.



Summary for Parkedale
US Patents:0
Tradenames:10
Ingredients:10
NDAs:16

Drugs and US Patents for Parkedale

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parkedale OPHTHOCORT chloramphenicol; hydrocortisone acetate; polymyxin b sulfate OINTMENT;OPHTHALMIC 050201-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Parkedale OPHTHOCHLOR chloramphenicol SOLUTION/DROPS;OPHTHALMIC 061220-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Parkedale THEELIN estrone INJECTABLE;INJECTION 003977-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Parkedale PROCAN SR procainamide hydrochloride TABLET, EXTENDED RELEASE;ORAL 088489-001 Jan 16, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Johnson and Johnson
McKinsey
Farmers Insurance
Cipla
Covington
Harvard Business School
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.